Editor’s Note October 25, 2011

OneMedForum SF 2012 is around the corner and we are gearing up to present some of the most promising companies and technologies, as well as innovative approaches to funding the growth economy. In this issue:

Alexei Marko, CEO of Neovasc [CVE:NVC]discusses the company’s innovative Reducer device used to treat refractory angina.

Peter Winter, consultant to the biotechnology industry, brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.

Dr. Andrew Barbash tells us how Virtual Healthcare is becoming the primary means by which people can collaborate and share decision making surrounding healthcare.

The comments are closed.